NEUROCRINE BIOSCIENCES INC - NOTE 2.250% 5/1

CUSIP: 64125CAD1

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Debt / NOTE 2.250% 5/1
Market price (% of par)
148.4%
Total 13F principal
$175,757,000
Principal change
+$248,000
Total reported market value
$262,221,324
Number of holders
31
Value change
+$3,515,689
Number of buys
7
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 64125CAD1?
CUSIP 64125CAD1 identifies 64125CAD1 - NEUROCRINE BIOSCIENCES INC - NOTE 2.250% 5/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NEUROCRINE BIOSCIENCES INC - NOTE 2.250% 5/1 as of Q3 2023

As of 30 Sep 2023, NEUROCRINE BIOSCIENCES INC - NOTE 2.250% 5/1 was held by 31 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $175,757,000 in principal (par value) of the bond. The largest 10 bondholders included FRANKLIN RESOURCES INC, TENOR CAPITAL MANAGEMENT Co., L.P., Invesco Ltd., SONA ASSET MANAGEMENT (US) LLC, CSS LLC/IL, D. E. Shaw & Co., Inc., LORD, ABBETT & CO. LLC, LORD, ABBETT & CO. LLC, Paloma Partners Management Co, and BNP PARIBAS ASSET MANAGEMENT Holding S.A.. This page lists 32 institutional bondholders reporting positions for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.